![Identification and Validation of the Methylated TWIST1 and NID2 Genes through Real-Time Methylation-Specific Polymerase Chain Reaction Assays for the Noninvasive Detection of Primary Bladder Cancer in Urine Samples - European Urology Identification and Validation of the Methylated TWIST1 and NID2 Genes through Real-Time Methylation-Specific Polymerase Chain Reaction Assays for the Noninvasive Detection of Primary Bladder Cancer in Urine Samples - European Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f36e8892-a0d1-428f-a85a-b21cb160e155/gr1_lrg.jpg)
Identification and Validation of the Methylated TWIST1 and NID2 Genes through Real-Time Methylation-Specific Polymerase Chain Reaction Assays for the Noninvasive Detection of Primary Bladder Cancer in Urine Samples - European Urology
![Clinical Decision Making in Surveillance of Non–Muscle-Invasive Bladder Cancer: The Evolving Roles of Urinary Cytology and Molecular Markers Clinical Decision Making in Surveillance of Non–Muscle-Invasive Bladder Cancer: The Evolving Roles of Urinary Cytology and Molecular Markers](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/d986ca59b324f447848bd0cac7b1c5d6105323c4-583x257.png/1712theo-table2.png?fit=crop&auto=format)
Clinical Decision Making in Surveillance of Non–Muscle-Invasive Bladder Cancer: The Evolving Roles of Urinary Cytology and Molecular Markers
Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes | PLOS ONE
Why do we need Urine Markers? - Activity Two:<br>Understanding Biomarker Performance for Bladder Cancer Surveillance - Educational Centre:<br>Current Clinical Problems in Bladder Cancer
![Clinical Decision Making in Surveillance of Non–Muscle-Invasive Bladder Cancer: The Evolving Roles of Urinary Cytology and Molecular Markers Clinical Decision Making in Surveillance of Non–Muscle-Invasive Bladder Cancer: The Evolving Roles of Urinary Cytology and Molecular Markers](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ee95e9a306b2de272195198c15a150ca4e0abb19-758x424.png/1712theo-table1.png?fit=crop&auto=format)
Clinical Decision Making in Surveillance of Non–Muscle-Invasive Bladder Cancer: The Evolving Roles of Urinary Cytology and Molecular Markers
Urinary Tumor Markers For Bladder Cancer I. Policy Description II. Related Policies III. Indications and/or Limitations of Cover
![Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 18 Issue 3 (2020) Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 18 Issue 3 (2020)](https://jnccn.org/view/journals/jnccn/18/3/full-jnccnGLS1803fx3.jpg)
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 18 Issue 3 (2020)
![Urinary biomarkers in bladder cancer: A review of the current landscape and future directions - ScienceDirect Urinary biomarkers in bladder cancer: A review of the current landscape and future directions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1078143920303689-gr1.jpg)
Urinary biomarkers in bladder cancer: A review of the current landscape and future directions - ScienceDirect
![Cells | Free Full-Text | Emerging Roles of Cancer Stem Cells in Bladder Cancer Progression, Tumorigenesis, and Resistance to Chemotherapy: A Potential Therapeutic Target for Bladder Cancer | HTML Cells | Free Full-Text | Emerging Roles of Cancer Stem Cells in Bladder Cancer Progression, Tumorigenesis, and Resistance to Chemotherapy: A Potential Therapeutic Target for Bladder Cancer | HTML](https://www.mdpi.com/cells/cells-09-00235/article_deploy/html/images/cells-09-00235-g001.png)
Cells | Free Full-Text | Emerging Roles of Cancer Stem Cells in Bladder Cancer Progression, Tumorigenesis, and Resistance to Chemotherapy: A Potential Therapeutic Target for Bladder Cancer | HTML
![Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy | Laboratory Investigation Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy | Laboratory Investigation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Flabinvest.2008.27/MediaObjects/41374_2008_Article_BFlabinvest200827_Fig1_HTML.gif)